News
The problem of path generation of planar mechanisms, or determining their motion as traced by a coupler curve, has been almost exclusively met with analytical solutions, leading to high run-time and ...
Ribosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...
Researchers at the University of Illinois Urbana-Champaign have discovered important new clues in the mystery of how an ...
An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to ...
An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to ...
Inclusion criteria: Adults (18 years old or older) taking antiplatelet drugs for at least 2 weeks; scheduled for elective or emergency neurosurgery under general anaesthesia (craniotomy, spinal cord ...
Aspirin was first introduced in 1896 by the German pharmaceutical manufacturer Bayer after being discovered by one of their researchers, chemist Felix Hoffmann (1868-1946). Box – container.
Drugs such as aspirin, 57 nonsteroidal antiinflammatory drugs, 58 penicillins ... and in very high doses impair synthesis of vitamin K–dependent clotting factors. 57,60,62 The risk of major bleeding ...
The current study designed and synthesized a series of acylhydrazone derivatives based on the natural product pogostone. Among them, compound 2a15 exhibited potent fungicidal activity against Valsa ...
Resistance and nonresponse to aspirin dramatically decreases its therapeutic efficacy. To overcome this issue, a small-molecule thrombus-targeting drug delivery system, aspirin-Arg-Gly-Asp-Val (A-RGDV ...
High-dose aspirin (HDA) is used with intravenous immunoglobulin (IVIg) in Kawasaki disease (KD). Practice regarding HDA varies, and it is unclear whether HDA duration affects the long-term course.
The probability of surviving past 36 months was 76.1% in the aspirin group and 84.9% in the placebo group, with an overall survival HR of 1.60 (95% CI 0.99–2.61, p=0.057) in favor of the placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results